1don MSN
New trial finds diabetes drug and nasal insulin improve brain health in early Alzheimer's disease
A clinical trial from Wake Forest University School of Medicine shows that two widely available medications, the diabetes ...
A light-activated graphene and black phosphorus biosensor detects Alzheimer's biomarkers in blood at zeptomole sensitivity, ...
A new MRI measure maps beat-to-beat brain-vessel pulses, revealing why some 60-year-old brains look “younger.” ...
Crossroads Neurovascular Inc. announced findings from the early clinical experience of the Path balloon guide catheter (BGC) ...
Coronary artery calcium (CAC) is a marker of subclinical atherosclerosis that confers increased risk of atherosclerotic cardiovascular disease. Measured by noncontrast cardiac computed tomography, CAC ...
Introduction Mitochondrial dysfunction and disrupted cerebral energy metabolism have been increasingly linked to the pathophysiology of schizophrenia. Preclinical studies suggest that certain atypical ...
Stroke risk evolves across the lifespan, with distinct sex-specific differences that remain underappreciated in both research ...
Treatment with anti-amyloid β antibodies is becoming standard therapy for early Alzheimer's disease, as lecanemab and donanemab received full approval in the USA, Japan, and other countries between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results